Victor Joo

835 total citations · 2 hit papers
12 papers, 454 citations indexed

About

Victor Joo is a scholar working on Oncology, Immunology and Infectious Diseases. According to data from OpenAlex, Victor Joo has authored 12 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in Victor Joo's work include Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (3 papers). Victor Joo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (3 papers). Victor Joo collaborates with scholars based in Switzerland, United States and France. Victor Joo's co-authors include Craig Fenwick, Giuseppe Pantaleo, Alessandra Noto, Matthieu Perreau, Riddhima Banga, Laurent Perez, Bruno E. Correia, Céline Pellaton, Thiruganesh Ramasamy and Ziyad S. Haidar and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Victor Joo

12 papers receiving 447 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T‐cell exhaustion in HIV infection

2019 246 citations Craig Fenwick, Victor Joo et al. Immunological Reviews profile →
Antibodies to combat viral infections: development strategies and progress

2022 139 citations Giuseppe Pantaleo, Bruno E. Correia et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Victor Joo Switzerland	7	171	159	123	106	98	12	454
Alex Olson United States	11	149 0.9×	109 0.7×	149 1.2×	42 0.4×	36 0.4×	21	351
Simone Topino Italy	13	177 1.0×	205 1.3×	110 0.9×	178 1.7×	196 2.0×	23	544
Hualin Li United States	13	381 2.2×	113 0.7×	217 1.8×	161 1.5×	54 0.6×	24	618
Pilar Mendoza United States	9	201 1.2×	262 1.6×	283 2.3×	71 0.7×	23 0.2×	12	509
Raphaëlle Parker United States	8	304 1.8×	71 0.4×	102 0.8×	149 1.4×	75 0.8×	10	458
Praveen K. Amancha United States	11	305 1.8×	162 1.0×	292 2.4×	117 1.1×	61 0.6×	26	638
Sandeep Narpala United States	10	367 2.1×	151 0.9×	145 1.2×	264 2.5×	114 1.2×	14	681
Samantha Reiss United States	7	360 2.1×	194 1.2×	102 0.8×	98 0.9×	49 0.5×	9	598
Lucie Bracq France	8	146 0.9×	127 0.8×	144 1.2×	55 0.5×	26 0.3×	10	366
Pedro A. Lamothe United States	10	262 1.5×	135 0.8×	89 0.7×	74 0.7×	42 0.4×	18	584

Countries citing papers authored by Victor Joo

Since Specialization

Citations

This map shows the geographic impact of Victor Joo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor Joo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor Joo more than expected).

Fields of papers citing papers by Victor Joo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor Joo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor Joo. The network helps show where Victor Joo may publish in the future.

Co-authorship network of co-authors of Victor Joo

This figure shows the co-authorship network connecting the top 25 collaborators of Victor Joo. A scholar is included among the top collaborators of Victor Joo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor Joo. Victor Joo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Bartolini, Robin, Lionel Trueb, Douglas Daoudlarian, et al.. (2025). Enrichment of CD7+CXCR3+ CAR T-cells in infusion products is associated with durable remission in relapsed or refractory diffuse large B-cell lymphoma. Annals of Oncology. 36(7). 749–761. 1 indexed citations

Daoudlarian, Douglas, et al.. (2024). Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study. Annals of Oncology. 36(1). 43–53. 10 indexed citations

Obéid, Michel, Victor Joo, Douglas Daoudlarian, et al.. (2024). High-dimensional longitudinal immune profiling uncovers a dual role of the CXCL9/CXCR3, CXCL13/CXCR5, and CCL11/CCL3 axis in the coupling of immune-related adverse events to immune checkpoint inhibitor response.. Journal of Clinical Oncology. 42(16_suppl). 2512–2512. 1 indexed citations

Joo, Victor, Alessandra Noto, Sofiya Latifyan, et al.. (2024). Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma. Nature Communications. 15(1). 3664–3664. 5 indexed citations

Joo, Victor, Constantinos Petrovas, Laurence de Leval, et al.. (2023). A CD64/FcγRI-mediated mechanism hijacks PD-1 from PD-L1/2 interaction and enhances anti-PD-1 functional recovery of exhausted T cells. Frontiers in Immunology. 14. 1213375–1213375. 3 indexed citations

Noto, Alessandra, Victor Joo, Madeleine Suffiotti, et al.. (2022). CXCL12 and CXCL13 Cytokine Serum Levels Are Associated with the Magnitude and the Quality of SARS-CoV-2 Humoral Responses. Viruses. 14(12). 2665–2665. 7 indexed citations

Pantaleo, Giuseppe, Bruno E. Correia, Craig Fenwick, Victor Joo, & Laurent Perez. (2022). Antibodies to combat viral infections: development strategies and progress. Nature Reviews Drug Discovery. 21(9). 676–696. 139 indexed citations breakdown →

Noto, Alessandra, Madeleine Suffiotti, Victor Joo, et al.. (2022). The deficiency in Th2-like Tfh cells affects the maturation and quality of HIV-specific B cell response in viremic infection. Frontiers in Immunology. 13. 960120–960120. 6 indexed citations

Fenwick, Craig, Victor Joo, Céline Pellaton, et al.. (2019). Tumor suppression of novel anti–PD-1 antibodies mediated through CD28 costimulatory pathway. The Journal of Experimental Medicine. 216(7). 1525–1541. 26 indexed citations

10.

Fenwick, Craig, Victor Joo, Alessandra Noto, et al.. (2019). T‐cell exhaustion in HIV infection. Immunological Reviews. 292(1). 149–163. 246 indexed citations breakdown →

11.

Fenwick, Craig, Victor Joo, Alex Farina, et al.. (2018). Novel anti-PD-1 antibodies not acting through PD-1/pdl-1 blockade that enhance tumor clearance.. Journal of Clinical Oncology. 36(15_suppl). e15118–e15118. 1 indexed citations

12.

Joo, Victor, Thiruganesh Ramasamy, & Ziyad S. Haidar. (2011). A Novel Self-Assembled Liposome-Based Polymeric Hydrogel for Cranio-Maxillofacial Applications: Preliminary Findings. Polymers. 3(2). 967–974. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact